Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi

被引:190
|
作者
Jahn, Andreas [1 ]
Floyd, Sian [1 ]
Crampin, Amelia C. [1 ]
Mwaungulu, Frank [2 ]
Mvula, Hazzie [2 ]
Munthali, Fipson [2 ]
McGrath, Nuala [1 ]
Mwafilaso, Johnbosco [2 ]
Mwinuka, Venance [2 ]
Mangongo, Bernard [2 ]
Fine, Paul E. M. [1 ]
Zaba, Basia [1 ]
Glynn, Judith R. [1 ]
机构
[1] Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England
[2] Karonga Prevent Study, Karonga, Malawi
来源
LANCET | 2008年 / 371卷 / 9624期
基金
英国惠康基金;
关键词
D O I
10.1016/S0140-6736(08)60693-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Malawi, which has about 80000 deaths from AIDS every year, made free antiretroviral therapy available to more than 80000 patients between 2004 and 2006. We aimed to investigate mortality in a population before and after the introduction of free antiretroviral therapy, and therefore to assess the effects of such programmes on survival at the population level. Methods We used a demographic surveillance system to measure mortality in a population of 32 000 in northern Malawi, from August, 2002, when free antiretroviral therapy was not available in the study district, until February, 2006, 8 months after a clinic opened. Causes of death were established through verbal autopsies (retrospective interviews). Patients who registered for antiretroviral therapy at the clinic were identified and linked to the population under surveillance. Trends in mortality were analysed by age, sex, cause of death, and zone of residence. Findings Before antiretroviral therapy became available in June, 2005, mortality in adults (aged 15-59 years) was 9.8 deaths for 1000 person-years of observation (95% CI 8.9-10.9). The probability of dying between the ages of 15 and 60 years was 43% (39-49) for men and 43% (38-47) for women; 229 of 352 deaths (65 . 1%) were attributed to AIDS. 8 months after the clinic that provided antiretroviral therapy opened, 107 adults from the study population had accessed treatment, out of an estimated 334 in need of treatment. Overall mortality in adults had decreased by 10% from 10 . 2 to 8.7 deaths for 1000 person-years of observation (adjusted rate ratio 0 . 90, 95% Cl 0 . 70-1.14). Mortality was reduced by 35% (adjusted rate ratio 0 . 65, 0.46.0 . 92) in adults near the main road, where mortality before antiretroviral therapy was highest (from 13.2 to 8.5 deaths per 1000 person-years of observation before and after antiretroviral therapy). Mortality in adults aged 60 years or older did not change. Interpretation Our findings of a reduction in mortality in adults aged between 15 and 59 years, with no change in those older than 60 years, suggests that deaths from AIDS were averted by the rapid scale-up of free antiretroviral therapy in rural Malawi, which led to a decline in adult mortality that was detectable at the population level. Funding Wellcome Trust and British Leprosy Relief Association.
引用
收藏
页码:1603 / 1611
页数:9
相关论文
共 35 条
  • [1] The population-level impact of public-sector antiretroviral therapy rollout on adult mortality in rural Malawi
    Payne, Collin F.
    Kohler, Hans-Peter
    [J]. DEMOGRAPHIC RESEARCH, 2017, 36 : 1081 - 1108
  • [2] Population-level adult mortality following the expansion of antiretroviral therapy in Rakai, Uganda
    Nabukalu, Dorean
    Reniers, Georges
    Risher, Kathryn A.
    Blom, Sylvia
    Slaymaker, Emma
    Kabudula, Chodziwadziwa
    Zaba, Basia
    Nalugoda, Fred
    Kigozi, Godfrey
    Makumbi, Fred
    Serwadda, David
    Reynolds, Steven J.
    Marston, Milly
    Eaton, Jeffrey W.
    Gray, Ron
    Wawer, Maria
    Sewankambo, Nelson
    Lutalo, Tom
    [J]. POPULATION STUDIES-A JOURNAL OF DEMOGRAPHY, 2020, 74 (01): : 93 - 102
  • [3] Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia
    Reniers, Georges
    Araya, Tekebash
    Davey, Gail
    Nagelkerke, Nico
    Berhane, Yemane
    Coutinho, Roel
    Sanders, Eduard J.
    [J]. AIDS, 2009, 23 (04) : 511 - 518
  • [4] Population-Level Reduction in Adult Mortality after Extension of Free Anti-Retroviral Therapy Provision into Rural Areas in Northern Malawi
    Floyd, Sian
    Molesworth, Anna
    Dube, Albert
    Banda, Emmanuel
    Jahn, Andreas
    Mwafulirwa, Charles
    Ngwira, Bagrey
    Branson, Keith
    Crampin, Amelia C.
    Zaba, Basia
    Glynn, Judith R.
    French, Neil
    [J]. PLOS ONE, 2010, 5 (10):
  • [5] The impact of antiretroviral therapy on population-level virulence evolution of HIV-1
    Roberts, Hannah E.
    Goulder, Philip J. R.
    McLean, Angela R.
    [J]. JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2015, 12 (113)
  • [6] Forecasting the Population-Level Impact of Reductions in HIV Antiretroviral Therapy in Papua New Guinea
    Gray, Richard T.
    Zhang, Lei
    Lupiwa, Tony
    Wilson, David P.
    [J]. AIDS RESEARCH AND TREATMENT, 2011, 2011
  • [7] Evolution of the Prison Population Mortality after Introduction Antiretroviral Therapy ( (ART)
    Marco, Andres
    [J]. REVISTA ESPANOLA DE SALUD PUBLICA, 2011, 85 (03): : 233 - 236
  • [8] Variation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africa
    Sloot, R.
    Maarman, G. J.
    Osman, M.
    Marx, F. M.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2018, 108 (08): : 606 - 606
  • [9] Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy Individual and Population-level References
    Keiser, Olivia
    Blaser, Nello
    Davies, Mary-Ann
    Wessa, Patrick
    Eley, Brian
    Moultrie, Harry
    Rabie, Helena
    Technau, Karl-Guenther
    Ndirangu, James
    Garone, Daniela
    Giddy, Janet
    Grimwood, Ashraf
    Gsponer, Thomas
    Egger, Matthias
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (10) : E254 - E259
  • [10] Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability
    Kimmel A.D.
    Resch S.C.
    Anglaret X.
    Daniels N.
    Goldie S.J.
    Danel C.
    Wong A.Y.
    Freedberg K.A.
    Weinstein M.C.
    [J]. Cost Effectiveness and Resource Allocation, 10 (1)